Dr Ilaria Iacobucci speaks at the 2019 ASH meeting about the results from a study that revealed the genetic underpinnings of acute myeloid leukaemia (AML) and myelodysplastic syndromes using genome and transcriptome sequencing.

She describes the specific mutational and structural changes identified in this study which may present new targets for therapy. 

Watch our interview with Dr Charles Mullighan here.

Read more about the study here.